根据提供的文献内容，我将按照要求提取并结构化信息，生成符合要求的JSON格式数据。以下是提取的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.137G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "137"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "46"
                    },
                    "Description in input context": "c.137G>A (p.E46K)"
                },
                {
                    "HGVS": "NM_000345.4:c.158A>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "T",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "V",
                        "position": "53"
                    },
                    "Description in input context": "c.158A>T (p.A53T)"
                },
                {
                    "HGVS": "NM_000345.4:c.137G>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "C",
                        "position": "137"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "A",
                        "position": "46"
                    },
                    "Description in input context": "c.137G>C (p.E46A)"
                },
                {
                    "HGVS": "NM_000345.4:c.248A>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "C",
                        "position": "248"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "A",
                        "position": "83"
                    },
                    "Description in input context": "c.248A>C (p.E83A)"
                },
                {
                    "HGVS": "NM_000345.4:c.248A>G",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "G",
                        "position": "248"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "83"
                    },
                    "Description in input context": "c.248A>G (p.E83K)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease (PD) / Dementia with Lewy bodies (DLB)",
        "MONDO": "MONDO:0005072"
    },
    "Experiment Method": [
        {
            "Assay Method": "Filament Assembly and Centrifugal Sedimentation",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant SNCA proteins",
                "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutation increased the propensity of SNCA to fibrillize compared with the WT protein."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
                },
                {
                    "Variant": "NM_000345.4:c.137G>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
                },
                {
                    "Variant": "NM_000345.4:c.248A>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                },
                {
                    "Variant": "NM_000345.4:c.248A>G",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All experiments were conducted multiple times."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Samples were run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA protein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without protein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "5"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Densitometry of Coomassie Blue-stained SDS-polyacrylamide gels or 125I quantitative Western blotting analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "K114 Fluorometry",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant SNCA proteins",
                "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutant polymerized more readily than the WT protein."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
                },
                {
                    "Variant": "NM_000345.4:c.137G>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
                },
                {
                    "Variant": "NM_000345.4:c.248A>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                },
                {
                    "Variant": "NM_000345.4:c.248A>G",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All experiments were conducted multiple times."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Samples were run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA protein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without protein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "5"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Fluorescence measurement with a SpectraMax Gemini fluorometer and SoftMax Pro 4.0 software."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "CD Spectrometry",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant SNCA proteins",
                "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutation converted from random coil conformation to β-sheet more readily than the WT protein."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
                },
                {
                    "Variant": "NM_000345.4:c.137G>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
                },
                {
                    "Variant": "NM_000345.4:c.248A>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                },
                {
                    "Variant": "NM_000345.4:c.248A>G",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All experiments were conducted multiple times."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Samples were run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA protein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without protein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "5"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "CD spectra were recorded using an Aviv model 202 spectrophotometer."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "ATR-FTIR Spectroscopy",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant SNCA proteins",
                "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutation converted from random coil conformation to β-sheet more readily than the WT protein."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
                },
                {
                    "Variant": "NM_000345.4:c.137G>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
                },
                {
                    "Variant": "NM_000345.4:c.248A>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                },
                {
                    "Variant": "NM_000345.4:c.248A>G",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All experiments were conducted multiple times."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Samples were run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA protein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without protein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "5"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ATR-FTIR spectra were collected on a Digilab FTS-60A equipped with a wide band MCT detector."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Negative Staining EM",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant SNCA proteins",
                "Description": "Human SNCA cDNA was cloned into the NdeI and HindIII restriction sites of the bacterial expression vector pRK172. The cDNAs coding for the mutant SNCA proteins E46A, E46K, E83A, and E83K were engineered by creating the corresponding nucleotide substitutions in the wild-type cDNA."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutant protein had a tendency to form compact bundles of fibrils."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation increased the propensity of SNCA to fibrillize to a greater extent than the E46K mutation."
                },
                {
                    "Variant": "NM_000345.4:c.137G>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46A mutation increased the propensity to polymerize, but this substitution resulted in two types of mature fibrils."
                },
                {
                    "Variant": "NM_000345.4:c.248A>C",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83A mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                },
                {
                    "Variant": "NM_000345.4:c.248A>G",
                    "Conclusion": "Increased",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E83K mutation increased the ability of SNCA to polymerize, but the resulting filaments showed reduced characteristics of true amyloid."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All experiments were conducted multiple times."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Samples were run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type SNCA protein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without protein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "5"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Images were captured with a Hamamatsu digital camera using AMT software."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明

1. **变体信息（Variants Include）**：提取了所有涉及的变体，并标准化了HGVS命名法。这些变体包括E46K、A53T、E46A、E83A和E83K。

2. **描述疾病（Described Disease）**：确定文献中研究的疾病为帕金森病（Parkinson's disease, PD）和路易体痴呆（Dementia with Lewy bodies, DLB），并从MONDO数据库检索了相应的术语。

3. **实验方法（Experiment Method）**：列出了文献中提到的所有实验方法，并详细描述了每种方法的材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法以及正常和异常结果的阈值。对于未在文献中明确提及的内容，使用"N.D."表示。

4. **批准的检测方法（Approved assay）**：判断每种实验方法是否通常用于研究该疾病，并进行了标注。

以上信息严格按照文献内容进行提取和组织，确保数据的准确性和一致性。